Edition:
United States

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

137.12USD
3:59pm EST
Change (% chg)

$1.25 (+0.92%)
Prev Close
$135.87
Open
$136.63
Day's High
$138.13
Day's Low
$135.88
Volume
57,688
Avg. Vol
91,236
52-wk High
$149.00
52-wk Low
$95.21

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

John Kozarich

67 2017 Non-Executive Independent Chairman of the Board

Matthew Foehr

44 2015 President, Chief Operating Officer

John Higgins

47 2015 Chief Executive Officer, Director

Matthew Korenberg

42 2015 Chief Financial Officer, Vice President - Finance

Charles Berkman

48 2007 Vice President, General Counsel, Secretary